CTIS2023-507028-22-00
Active, not recruiting
Phase 1
The impact of ovarian stimulation intensity on embryo euploidy in advanced age women. A randomized controlled trial - FSD-INO-2023-14
Santiago Dexeus Font Fundacio Privada0 sites110 target enrollmentSeptember 7, 2023
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Infertility
- Sponsor
- Santiago Dexeus Font Fundacio Privada
- Enrollment
- 110
- Status
- Active, not recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Infertile patients with indication for IVF, Undergoing preimplantation genetic screening cycles, Age \>\= 38 and \< 42 years old, AMH \> 1\.5 ng/ml and \< 3\.5 ng/ml (AMH result of up to one year will be valid), BMI 18\.5 – 30 Kg/m2
Exclusion Criteria
- •Severe male factor requiring TESE (testicular sperm extraction), Administration of any other drug potentially interfering with the treatment, Contraindication for hormonal treatment, Recent history of severe disease requiring regular treatment (clinically significant concurrent medical condition that could compromise subject safety or interfered with the trial assessment)., Monogenic disease to be detected with PGT\-M
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
INTEnsity of ovariaN Stimulation and Embryo QualityTo compare the number of GQB and the morphokinetic parameters of early embryo development in infertile suboptimal patients undergoing two different intensities of ovarian stimulation, a milder approach ( Clomiphene Citrate (CC) 50mg/day plus 150IU daily dose of rFSH) and a more intense approach (300IU daily dose of rFSH).MedDRA version: 20.0Level: PTClassification code 10021928Term: Infertility femaleSystem Organ Class: 10038604 - Reproductive system and breast disordersMedDRA version: 21.0Level: PTClassification code 10021926Term: InfertilitySystem Organ Class: 10038604 - Reproductive system and breast disordersMedDRA version: 20.0Level: LLTClassification code 10021930Term: Infertility NOSSystem Organ Class: 10038604 - Reproductive system and breast disordersMedDRA version: 20.0Level: PTClassification code 10021929Term: Infertility maleSystem Organ Class: 10038604 - Reproductive system and breast disordersMedDRA version: 20.1Level: LLTClassification code 10016399Term: Female infertility (primary)System Organ Class: 10038604 - Reproductive system and breast disordersMedDRA version: 21.1Level: LLTClassification code 10039843Term: Secondary infertility (female)System Organ Class: 10038604 - Reproductive system and breast disordersTherapeutic area: Diseases [C] - Female diseases of the urinary and reproductive systems and pregancy complications [C13]EUCTR2021-000941-42-ESFundacion Santiago Dexeus Font100
Recruiting
Phase 4
INtensity of OVarian Stimualtion and Euploid EmbryosFertilityNCT06154083Fundación Santiago Dexeus Font110
Completed
Not Applicable
effect of ovarian stimulation drugs on incidance of unruptured follicleCondition 1: luteinized unruptured follicle. Condition 2: luteinized unruptured follicle.Female infertility associated with anovulationFemale infertility, unspecifiedIRCT2014091019113N1Tehran University Of Medical Sciences180
Not yet recruiting
Not Applicable
Effect of repeated egg donation cyclesHealth Condition 1: O00-O9A- Pregnancy, childbirth and the puerperiumCTRI/2020/04/024704Dr Manish Banker
Completed
Phase 2
Assessment the effect of ovarian stimulation with and without letrozole in IVF/ICSI outcomes.IRCT201701291952N8Vice Chancellor for research, Tehran University of Medical Science160